CLINICAL_TRIALS
trial_result
· 2020-09-01
Clinical Trial Update: A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine [Phase 1]
Summary
Phase 1 study assessing lasmiditan in children 6 to 17 with migraine has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2020-09-01